Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
Authors Zhao Y, Wang H, Yang Y, Jia W, Su T, Che Y, Feng Y, Yuan X, Wang X
Received 11 January 2021
Accepted for publication 11 January 2021
Published 15 January 2021 Volume 2021:16 Pages 469—470
Zhao Y, Wang H, Yang Y, et al. Int J Nanomedicine. 2020:15:9571–9586
The authors have advised Figure 4F on page 9579 is incorrect. Due to an error at the time of figure assembly the representative image from free E7/CpG group twice instead the image of Lip E7/CpG. The correct Figure 4 is shown below.
The authors apologize for this error and advise it does not affect the results of the paper.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]